Search
for
Sort by
Research 31–60 of 1000+
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice
- Novel inhibitors of 5α-reductase
- Synthesis and in vitro study of 17β-[N-ureylene-N,N′-disubstituted]-4-methyl-4-aza-5α-androstan-3-ones as selective inhibitors of type I 5α-reductase
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Clinical use of 5α-reductase inhibitors
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- An improved synthesis of finasteride from 4-androsten-3,17-dione
- Idiopathic Hirsutism*
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Effect of finasteride on the ovulatory function of normal women
- Biosynthesis of Dihydrotestosterone by a Pathway that Does Not Require Testosterone as an Intermediate in the SZ95 Sebaceous Gland Cell Line
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- The Development of BL 7660 as an Anti‐Acne Agent
- Androgenetic alopecia; drug safety and therapeutic strategies
- Skin steroidogenesis in health and disease
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- 25 years of ERβ: a personal journey
- Serum C-19 steroid sulphates in females with clinical hyperandrogenism
- Steroid Hormones
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Androgens and androgen receptor action in skin and hair follicles
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- In vitro and In vivo Effects of 17β-N-(4-phenylcarbamoyl) androst-4-en-3- one Derivatives as 5a-reductase Inhibitors on Androgen-dependent Glands
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- Post-finasteride syndrome – does it really exist?
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Comparison of Finasteride (Proscar®) and Serenoa repens (Permixon®) in the Inhibition of 5-Alpha Reductase in Healthy Male Volunteers